Compositions and methods comprising a biocidal polyamine

US9439433B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9439433-B2
Application numberUS-201414507701-A
CountryUS
Kind codeB2
Filing dateOct 6, 2014
Priority dateMay 22, 2013
Publication dateSep 13, 2016
Grant dateSep 13, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compounds, compositions, and methods comprising a polyamine compound are described, which may be used to kill, disperse, treat, or reduce biofilms, or to inhibit or substantially prevent biofilm formation. In certain aspects, the present invention relates to compounds, compositions, and methods comprising polyamine compounds that have antimicrobial or dispersing activity against a variety of bacterial strains capable of forming biofilms.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for dispersing or killing a biofilm, the method comprising a step of contacting the biofilm with an anti-biofilm composition, thereby dispersing or killing the biofilm; wherein the anti-biofilm composition comprises a polyamine compound selected from the group consisting of and a salt thereof; wherein: each R a is a member independently selected from the group consisting of A 1 , A 2 , A 3 , A 4 and A 5 are each an A n member independently selected from the group consisting of N, CR a , and CR 5 ; or, alternatively, a pair of adjacent A n members join to form an additional, independently selected aryl, cycloalkyl, heterocyclyl, or heterocycloaryl ring; wherein at least one A n member and at most three A n members are each an independently selected CR a ; each R 1a , R 1b , R 1c , and R 1d is a member independently selected from the group consisting of hydrogen, fluoro, alkyl, and fluoroalkyl; each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl; alternatively, a pair of R 2 members from the same R a group independently selected from the group R 2a and R 2b , R 2c and R 2d , and R 2e and R 2f join to form a member independently selected from the group consisting of spirocycloalkyl, spiroheterocycyl, and oxo; or, alternatively, an R 2a and an R 2c from the same R a group join to form a ring that is independently selected from the group consisting of cycloalkyl and heterocycyl; each R m is a member independently selected from the group consisting of —CR 2a R 2b —, —C(R 2a )═(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L-C(R 2c )(R 2d )—; each m is an integer independently selected from 1 to 16; each L is a member independently selected from the group consisting of a bond, —O—, —C(O)O—, —NR 4 —, —NR 4 C(O)—, and —C(O)NR 4 —; each R 3 is a member independently selected from the group consisting of —Z 1 —R 4 , —Z 1 —Y 1 —R 4 , —Z 1 —Y 1 —Y 2 —R 4 , and —Z 1 —Y 1 —Y 2 —Y 3 —R 4 ; each R 4 is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, cycloalkyl, heteroaryl, arylalkyl, cycloalkylalkyl, and heteroarylalkyl; or, alternatively, for an —N(R 4 ) 2 group, one of the two R 4 in the group is a member selected from the group consisting of —(CO)OR 6a —, —(CO)N(R 6a )(R 6b ), and —C(NR 6a )N(R 6b )(R 6c ); or, alternatively, for an —N(R 4 ) 2 group, the two R 4 groups join to form a heterocyclic ring; each R 5 is a member independently selected from the group consisting of hydrogen, alkyl, hydroxyl, alkoxy, aminoalkoxy, alkylamino, alkylaminoalkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkoxy, cycloalkylalkoxy, cycloalkylamino, cycloalkylalkylamino, heterocyclyl, heterocycyloxy, heterocycylamino, halo, haloalkyl, fluoroalkyloxy, arylalkyl, arylalkyloxy, arylalkylamino, n6m-heteroaryl, n6m-heteroaryloxy, heteroarylalkyl, heteroarylalkyloxy, heteroarylalkylamino, hydroxyalkyl, aminoalkyl, and alkylaminoalkyl; wherein at least one R 5 is not hydrogen; each Y 1 , Y 2 , and Y 3 is an independently selected group of Formula IA: each Z 1 and Z 2 is a member independently selected from the group consisting of —N(R 4 )— and —O—; and each R 6a , R 6b , and R 6c is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, arylalkyl, heteroarylalkyl, and cycloalkylalkyl; or, alternatively, two R 6n members R 6a and R 6b or R 6a and R 6c join to form a heterocycyl ring; wherein the polyamine compound comprises at least two primary or secondary amino groups; and with the proviso that —Z 1 —R 4 and —Z 2 —R 4 are not —NH 2 . 2. The method of claim 1 , wherein the biofilm comprises an antibiotic-resistant bacterial species. 3. The method of claim 1 , wherein the polyamine compound comprises at least four primary or secondary amino groups. 4. The method of claim 1 , wherein the polyamine compound comprises at least six primary or secondary amino groups. 5. The method of claim 1 , wherein the polyamine compound is a hydrochloride salt of 6. The method of claim 3 , wherein the polyamine compound is selected from the group consisting of and a salt thereof; wherein each A n member is an independently selected CR 5 . 7. The method of claim 6 , wherein: each R a is independently a group of Formula II: each of the A n members is independently selected from the group consisting of CR a and CR 5 ; or, alternatively, a pair of adjacent A n members join to form an additional, independently selected cycloalkyl, aryl, heterocyclyl, or heterocycloaryl ring; each R 1a , R 1b , R 1c , and R 1d is a member independently selected from the group consisting of hydrogen, fluoro, alkyl, and fluoroalkyl; and for each R a member, at most two R m of the R a member are selected from the group consisting of —C(R 2a )═(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L-C(R 2c )(R 2d ). 8. The method of claim 7 , wherein: each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl; alternatively, a pair of R 2n members from the R a group independently selected from the group R 2a and R 2b , R 2c and R 2d , and R 2e and R 2f join to form a ring independently selected from the group consisting of spirocycloalkyl and spiroheterocycyl; or, alternatively, the R 2a and the R 2c from the R a group join to form a ring independently selected from the group consisting of cycloalkyl and heterocycyl; each m is an integer independently selected from 1 to 12; each R 3 is a member independently selected from the group consisting of —Z 1 —Y 1 —R 4 and —Z 1 —Y 1 —Y 2 —R 4 ; and each Z 1 and Z 2 is an independently selected NR 4 . 9. The method of claim 6 , wherein: A 1 , A 2 , A 3 , A 4 , and A 5 are each an A n member independently selected from the group consisting of CR a , and CR 5 ; or, alternatively, a pair of adjacent A n members join to form an additional cycloalkyl, aryl, heterocyclyl, or heterocycloaryl ring; each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; each m is an integer independently selected from 1 to 10; each L is a member independently selected from the group consisting of a bond, —O—, and —NR 4 —; each R 3 is a member independently selected from the group consisting of —Z 1 —R 4 , —Z 1 —Y 1 —R 4 , and —Z 1 —Y 1 —Y 2 —R 4 ; and each Z 1 and Z 2 is an independently selected NR 4 . 10. The method of claim 9 , wherein: each R a is independently a group of Formula V:

Assignees

Inventors

Classifications

  • Laboratory, medical or dentistry appliances, e.g. catheters or sharps · CPC title

  • Living organisms or biological materials · CPC title

  • Anti-perspirants or body deodorants (deodorisation of air A61L9/00) · CPC title

  • Radicals substituted by nitrogen atoms (nitro radicals C07D317/52) · CPC title

  • Amines · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9439433B2 cover?
Compounds, compositions, and methods comprising a polyamine compound are described, which may be used to kill, disperse, treat, or reduce biofilms, or to inhibit or substantially prevent biofilm formation. In certain aspects, the present invention relates to compounds, compositions, and methods comprising polyamine compounds that have antimicrobial or dispersing activity against a variety of ba…
Who is the assignee on this patent?
Curza Global Llc, Univ Utah Res Found
What technology area does this patent fall under?
Primary CPC classification A01N47/28. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).